To explore the incidence of CD8+ lymphocytes and their colocation within NSCLC tumors, dual color IF for PD-L1 and CD8 was used to analyze 95 NSCLC patient samples in our study. This evidence concerns the gene CD8A and non-small cell lung carcinoma.